Ad is loading...
GCIIX
Price
$14.80
Change
-$0.10 (-0.67%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GCIIX vs VTSNX

Header iconGCIIX vs VTSNX Comparison
Open Charts GCIIX vs VTSNXBanner chart's image
Goldman Sachs Intl Eq Insghts Instl
Price$14.80
Change-$0.10 (-0.67%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GCIIX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCIIX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCIIX is a StrongSell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GCIIX (1.77B). VTSNX pays higher dividends than GCIIX: VTSNX (3.29) vs GCIIX (2.58). GCIIX was incepted earlier than VTSNX: GCIIX (27 years) vs VTSNX (14 years). GCIIX is a more actively managed with annual turnover of: 157.00 vs. VTSNX (4.00). GCIIX has a lower initial minimum investment than VTSNX: GCIIX (1000000) vs VTSNX (5000000). GCIIX annual gain was more profitable for investors over the last year : 14.45 vs. VTSNX (10.92). GCIIX return over 5 years is better than : 28.98 vs. VTSNX (15.91).
GCIIXVTSNXGCIIX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years14 years-
Gain YTD6.7824.535150%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.77B442B0%
Annual Yield % from dividends2.583.2979%
Returns for 1 year14.4510.92132%
Returns for 3 years6.46-5.86-110%
Returns for 5 years28.9815.91182%
Returns for 10 years70.5329.81237%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals